Medicine
Enoxaparin 300 mg/3 mL injection
Enoxaparin 300 mg/3 mL injection is a generic prescription medicine for intravenous, subcutaneous use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F). Store in…
Key facts
- Active ingredient (INN)
- Enoxaparin
- Brand
- Sold under the generic name
- Strength
- 300 mg/3 mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 1 vial of 3 mL and 3 more
- Manufacturers
- Fresenius KabiMeitheal PharmaceuticalsAmphastar PharmaceuticalsBluePoint Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F). Store in the original carton or packaging until ready to use. Do not store the multiple-dose vials for more than 28 days after the first use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AB05 Enoxaparin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 June 2019
- Identifiers
- RxCUI 854228, 854235, 854238 +5DailyMed set ID 21b095d1-5ade-43e9-9114-30fbfb2331c9, 066f27ec-352c-4051-ba29-248e292690db, 7d38c307-767f-4c38-ac0e-b8bb62782602 +3NDC 63323-539, 71288-426, 68001-641 +1Application NDA020164, ANDA214856, ANDA208600
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 carton / 3 mL in 1 vial, multi-dose | 63323-539-03 | Fresenius Kabi | 18 June 2019 |
| 1 vial, multi-dose in 1 carton / 3 mL in 1 vial, multi-dose | 63323-539-13 | Fresenius Kabi | 18 June 2019 |
| 1 vial, multi-dose in 1 carton / 3 mL in 1 vial, multi-dose | 71288-426-03 | Meitheal Pharmaceuticals | 14 June 2022 |
| 1 vial, multi-dose in 1 carton / 3 mL in 1 vial, multi-dose | 71288-426-91 | Meitheal Pharmaceuticals | 14 June 2022 |
| 1 vial in 1 carton / 3 mL in 1 vial | 0548-5608-00 | Amphastar Pharmaceuticals | 11 November 2019 |
| 1 vial, multi-dose in 1 carton / 3 mL in 1 vial, multi-dose | 68001-641-41 | BluePoint Laboratories | 1 May 2025 |
| 1 vial, multi-dose in 1 carton / 3 mL in 1 vial, multi-dose | 0955-1016-01 | — | 3 October 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Enoxaparin 300 mg/3 mL injection.
Other strengths and forms of Enoxaparin
Clinical summary
Enoxaparin is a low molecular weight heparin indicated for prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness. MedsAcross supplies Enoxaparin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EnoxaparinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Enoxaparin sodium prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Inhixa: European public assessment report (EPAR) · European Medicines Agency
Need Enoxaparin 300 mg/3 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.